KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash & Current Investments (2016 - 2025)

Astrana Health's Cash & Current Investments history spans 16 years, with the latest figure at $1.2 million for Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 99.65% year-over-year to $1.2 million; the TTM value through Jun 2025 reached $339.7 million, up 3.67%, while the annual FY2024 figure was $290.8 million, 1.85% down from the prior year.
  • Cash & Current Investments for Q3 2025 was $1.2 million at Astrana Health, down from $339.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $364.5 million in Q2 2021 and bottomed at $1.2 million in Q3 2025.
  • The 5-year median for Cash & Current Investments is $290.8 million (2024), against an average of $281.7 million.
  • The largest annual shift saw Cash & Current Investments soared 236.9% in 2021 before it crashed 99.65% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $261.5 million in 2021, then rose by 12.28% to $293.6 million in 2022, then rose by 0.92% to $296.3 million in 2023, then decreased by 1.85% to $290.8 million in 2024, then tumbled by 99.58% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Cash & Current Investments are $1.2 million (Q3 2025), $339.7 million (Q2 2025), and $258.5 million (Q1 2025).